Federal regulators have signed off on a new type of flu vaccine with a booster in it, with the hope of better protecting seniors from the virus.
It’s the first flu vaccine to include what’s called an adjuvant — a compound that helps stimulate the immune system so that a vaccine is more effective.
It’s aimed at people over 65, who typically have a poor immune response to vaccines.
“Immunizing individuals in this age group is especially important because they bear the greatest burden of severe influenza disease and account…
Read the rest of the story from our partners at NBC News.
More Must-Reads From TIME
- What We Know So Far About the Deadly Earthquakes in Turkey and Syria
- Beyoncé's Album of the Year Snub Fits Into the Grammys' Long History of Overlooking Black Women
- How the U.S. Shot Down the Alleged Chinese Spy Balloon
- Effective Altruism Has a Toxic Culture of Sexual Harassment and Abuse, Women Say
- Inside Bolsonaro's Surreal New Life as a Florida Man—and MAGA Darling
- 'Return to Office' Plans Spell Trouble for Working Moms
- 8 Ways to Read More Books—and Why You Should
- Why Aren't Movies Sexy Anymore?
- How Logan Paul's Crypto Empire Fell Apart